Roadshow
INVISION Leukemia INLab NGS
1. Ultra-Sensitive Blood Testing for Alzheimer’s Disease
INB leverages its proprietary FOPPR technology to provide non-invasive, rapid, and cost-effective blood-based testing for early detection and disease monitoring of Alzheimer’s disease. Our optical biosensing POCT platform offers a fully integrated solution—from antibody analysis to reagent development—and has been adopted as a core diagnostic technology in the EU TAuimMunE (TAME) program. This approach overcomes the complexity of conventional biomarker assays, enabling more accessible, accurate early diagnosis and longitudinal monitoring.
2. INVISION INLab NGS Precision Medicine Solution
The INVISION INLab NGS solution provides a fully integrated, end-to-end platform—from sample processing to clinical reporting—and is implemented in CAP-accredited laboratories in the United States.
Key advantages include:
✅Automated, end-to-end workflow: Streamlines operations from sample to report, reducing labor dependency and turnaround time
✅DimerOff library preparation technology: Minimizes primer dimer and non-specific interference, improving library quality and data accuracy
✅Fully automated bioinformatics analysis: Standardized pipelines generate clinically actionable results without requiring dedicated bioinformatics expertise
✅Cost-optimized design: Reduces per-test cost and enhances scalability through workflow simplification and system integration
✅Flexible gene panel customization: Supports diverse clinical applications through disease-specific panel design
3. Partnership Opportunities
Distributors, Biotech & Pharmaceutical Companies: For global market expansion and co-development
Hospitals & CROs: To establish and implement precision medicine capabilities
Scientists & Research Institutions: For collaborative research and grant programs
- Established 2016
- Company Instant NanoBiosensors Co., Ltd.
- Telephone +886-2-2653-8655
- Email cmo@instantnao.com
- Address RM.C328, 3rd FLOOR,NO99, LN. 130, SEC. 1, ACADEMIA RD., NANGANG DIST. TAIPEI, TAIWAN 115
Instant NanoBiosensors Co., Ltd. (INB) is an innovative precision diagnostics company focused on two core technology domains: ultra-sensitive protein biomarker detection and the INVISION INLab NGS precision medicine solution. We deliver rapid, accurate, and cost-effective detection and analysis platfomrs.
1. Ultra-Sensitive Blood Testing for Alzheimer’s Disease
INB leverages its proprietary FOPPR technology to provide non-invasive, rapid, and cost-effective blood-based testing for early detection and disease monitoring of Alzheimer’s disease. Our optical biosensing POCT platform offers a fully integrated solution—from antibody analysis to reagent development—and has been adopted as a core diagnostic technology in the EU TAuimMunE (TAME) program. This approach overcomes the complexity of conventional biomarker assays, enabling more accessible, accurate early diagnosis and longitudinal monitoring.
2. INVISION INLab NGS Precision Medicine Solution
The INVISION INLab NGS solution provides a fully integrated, end-to-end platform—from sample processing to clinical reporting—and is implemented in CAP-accredited laboratories in the United States.
Key advantages include:
✅Automated, end-to-end workflow: Streamlines operations from sample to report, reducing labor dependency and turnaround time
✅DimerOff library preparation technology: Minimizes primer dimer and non-specific interference, improving library quality and data accuracy
✅Fully automated bioinformatics analysis: Standardized pipelines generate clinically actionable results without requiring dedicated bioinformatics expertise
✅Cost-optimized design: Reduces per-test cost and enhances scalability through workflow simplification and system integration
✅Flexible gene panel customization: Supports diverse clinical applications through disease-specific panel design
3. Partnership Opportunities
Distributors, Biotech & Pharmaceutical Companies: For global market expansion and co-development
Hospitals & CROs: To establish and implement precision medicine capabilities
Scientists & Research Institutions: For collaborative research and grant programs